VICTORIA, British Columbia—Translational research software firm GenoLogics Life Sciences Software Inc. announced Nov. 10 it signed a three-year, global agreement with Pfizer to provide informatics solutions to its research labs. Under the terms of the agreement, GenoLogics will provide an enterprise-enabled lab and data management system to capture, contextualize and integrate science data at multiple Pfizer locations.
The companies said the ability to leverage data standards across labs by virtue of a common informatics platform will provide Pfizer with the tools to enable Web-based collaboration, bioinformatics pipelining, auditability and reporting of cross-science data. Financial details of the deal were not made available. DDN
The companies said the ability to leverage data standards across labs by virtue of a common informatics platform will provide Pfizer with the tools to enable Web-based collaboration, bioinformatics pipelining, auditability and reporting of cross-science data. Financial details of the deal were not made available. DDN
